Clinical Utility and Health Outcomes Study of the DecisionDx®-SCC Prognostic Gene Expression Profile Test (UTILISE)
Categories (click each to see list of all clinical trials associated with that category): Dermatology (ONC)
Current Status: Open
Phase: N/A (Cancer Prevention)
Principal Investigator: Wysong, Ashley
Contact Information:
Lucinda Kustka
lucinda.kustka@unmc.edu
Summary
Objectives:
Primary Objective: To determine the utility of the DecisionDx®-SCC test results on clinical management decisions in early adoption and routine use.
Secondary Objectives:
To observe changes in clinical utilization of DecisionDx®-SCC and characterize the clinically tested population.
To determine metastasis free survival (MFS) in patients clinically tested with DecisionDx®-SCC.
To evaluate alternate genes important for prognosis, diagnosis and prediction, as well as alternative genomic or transcriptomic platforms that improve prediction of outcomes for patients clinically tested with DecisionDx®SCC.